Novartis plans to cut their global work force by 2500 jobs to save $1.6 billion. Novartis Vaccines and Diagnostics division in Emeryville and the bulk drug manufacturing facility in Vacaville will be unaffected.
Wednesday, December 26, 2007
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment